Status:
ACTIVE_NOT_RECRUITING
Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
Lead Sponsor:
Epion Therapeutics
Conditions:
Keratoconus
Eligibility:
All Genders
8-45 years
Phase:
PHASE3
Brief Summary
A Multicenter, Randomized, Double-Masked, Sham-Controlled, Parallel-Group Phase 3 Study to Evaluate the Efficacy and Safety of Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With...
Eligibility Criteria
Inclusion
- Diagnosis of keratoconus
Exclusion
- Minimal corneal thickness \< 350 microns
- Non-keratoconic ectatic disease
- Contraindications or hypersensitivities to any required study medications
- Pregnancy or breastfeeding
- Certain concomitant ocular conditions
Key Trial Info
Start Date :
October 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06100939
Start Date
October 30 2023
End Date
October 1 2025
Last Update
May 1 2025
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Nvision Eye Centers Rowland Heights
Rowland Heights, California, United States, 91748
2
Goodman Eye Center
San Francisco, California, United States, 94115
3
Center for Excellence in Eye Care
Miami, Florida, United States, 33176
4
Chicago Cornea Consultants
Hoffman Estates, Illinois, United States, 60169